Literature DB >> 10909966

Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-alpha and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice.

D G Alleva1, R P Pavlovich, C Grant, S B Kaser, D I Beller.   

Abstract

Cytokines derived from macrophages (Mø) play a critical role in the development of type 1 diabetes in the nonobese diabetic (NOD) mouse. Based on earlier findings from lupus-prone strains of inherent cytokine defects in Mø , NOD Mø were evaluated for intrinsically dysregulated cytokine production with the potential to initiate or exacerbate disease. Endotoxin-activated peritoneal Mø from young prediseased NOD mice produced interleukin (IL)-1 and tumor necrosis factor (TNF)-alpha levels similar to those of Mø from a panel of control strains but reduced compared with the congenic diabetes-resistant NOR strain. IL-6 and IL-10 production were similar in NOD and NOR Mø, indicating that reduction in NOD IL-1 and TNF-alpha expression was selective. Nevertheless, the ratio of TNF-alpha and IL-10 production, a stringent index of normal Mø function, distinguished NOD from all normal strains. The most striking feature of NOD Mø, however, was their substantially elevated IL-12 production. This response was induced not only by endotoxin but also by bacillus Calmette-Guerin (BCG) and CD40 ligand and was associated with (and likely caused by) the enhanced and prolonged expression of p40 mRNA. Moreover, NOD Mø IL-12 expression appeared to be near maximally induced by lipopolysaccharide (LPS) alone, because it was only slightly enhanced by the addition of gamma-interferon, a stimulus that substantially elevated LPS-induced IL-12 production in Mø from normal strains. Accompanied by a unique profile of TNF-alpha and IL-10, the dramatic elevation of IL-12 expression by NOD Mø reflects intrinsic defects of the innate immune system with the potential to initiate and propagate the pathogenic autoreactive T-helper type 1 response characteristic of type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10909966     DOI: 10.2337/diabetes.49.7.1106

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  31 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

2.  Modeling toxicodynamic effects of trichloroethylene on liver in mouse model of autoimmune hepatitis.

Authors:  Kathleen M Gilbert; Brad Reisfeld; Todd J Zurlinden; Meagan N Kreps; Stephen W Erickson; Sarah J Blossom
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-12       Impact factor: 4.219

3.  Macrophages from nonobese diabetic mouse have a selective defect in IFN-γ but not IFN-α/β receptor pathway.

Authors:  Myung-Shik Lee; Hyung-Joon Kwon; Hun Sik Kim
Journal:  J Clin Immunol       Date:  2012-03-07       Impact factor: 8.317

Review 4.  Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.

Authors:  Zejun Zhou; Miao Ding; Lei Huang; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2016-09-09       Impact factor: 3.969

5.  NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

Authors:  Lisa M Maier; Sarah K Howlett; Kara M Rainbow; Jan Clark; Joanna M M Howson; John A Todd; Linda S Wicker
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

6.  PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice.

Authors:  Taku Yoshida; Fang Jiang; Tasuku Honjo; Taku Okazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-25       Impact factor: 11.205

Review 7.  Autologous umbilical cord blood infusion for type 1 diabetes.

Authors:  Michael J Haller; Hilla-Lee Viener; Clive Wasserfall; Todd Brusko; Mark A Atkinson; Desmond A Schatz
Journal:  Exp Hematol       Date:  2008-03-20       Impact factor: 3.084

8.  Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice.

Authors:  A C Vasquez; M Feili-Hariri; R J Tan; P A Morel
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

9.  Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

Authors:  C Gysemans; K Stoffels; A Giulietti; L Overbergh; M Waer; M Lannoo; U Feige; C Mathieu
Journal:  Diabetologia       Date:  2003-07-17       Impact factor: 10.122

10.  Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.

Authors:  Robin A Herlands; Jacqueline William; Uri Hershberg; Mark J Shlomchik
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.